Cigna Group's (CI) Overweight Rating Reiterated at Cantor Fitzgerald

Key Points

• Cantor Fitzgerald reiterated its Overweight rating on Cigna and set a $340 price target, implying 12.7% upside from the prior close.
• Analyst sentiment is broadly positive: 14 analysts rate the stock Buy and eight Hold, for a MarketBeat consensus of Moderate Buy and an average target of $336.40.
• Cigna beat quarterly estimates, reporting adjusted EPS of $7.98 and revenue of $73.79 billion, up 5.6% year over year. However, GAAP net income and reported EPS fell compared with the year-ago quarter.

Cigna Group (NYSE:CI - Get Free Report)'s stock had its "overweight" rating reissued by equities research analysts at Cantor Fitzgerald in a report released on Friday, Benzinga reports. They presently have a $340.00 price objective on the health services provider's stock. Cantor Fitzgerald's price target indicates a potential upside of 12.70% from the stock's previous close.

CI has been the topic of several other reports. Raymond James Financial downgraded shares of Cigna Group from a "strong-buy" rating to an "outperform" rating and dropped their price objective for the company from $350.00 to $320.00 in a report on Monday, August 3rd. Wells Fargo & Company boosted their price target on shares of Cigna Group from $305.00 to $307.00 and gave the company an "equal weight" rating in a research report on Friday, July 31st. Jefferies Financial Group cut shares of Cigna Group from a "buy" rating to a "hold" rating and dropped their price target for the company from $336.00 to $307.00 in a research note on Tuesday, August 4th. Barclays raised their price objective on shares of Cigna Group from $304.00 to $310.00 and gave the stock an "equal weight" rating in a report on Friday, July 31st. Finally, Royal Bank Of Canada reiterated an "outperform" rating and issued a $337.00 price objective on shares of Cigna Group in a research note on Thursday, October 1st. Fourteen equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $336.40.

Cigna Group Stock Performance

Shares of Cigna Group stock opened at $301.67 on Friday. The company has a market cap of $79.71 billion, a PE ratio of 9.70, a price-to-earnings-growth ratio of 1.03 and a beta of 0.25. Cigna Group has a 52 week low of $255.53 and a 52 week high of $318.05. The business has a 50 day moving average price of $285.48 and a 200-day moving average price of $282.05. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68.

Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings results on Thursday, November 5th. The health services provider reported $7.98 EPS for the quarter, topping analysts' consensus estimates of $7.52 by $0.46. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%. The business had revenue of $73.79 billion for the quarter, compared to analyst estimates of $72.64 billion. During the same period last year, the company posted $7.83 earnings per share. Cigna Group's quarterly revenue was up 5.6% compared to the same quarter last year. Equities analysts anticipate that Cigna Group will post 30.49 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Nicole S. Jones sold 2,677 shares of the stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total transaction of $748,515.97. Following the completion of the sale, the insider directly owned 25,880 shares in the company, valued at approximately $7,236,306.80. This represents a 9.37% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the sale, the insider owned 5,053 shares of the company's stock, valued at approximately $1,435,304.65. This trade represents a 10.88% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company's stock.

Institutional Investors Weigh In On Cigna Group

Several hedge funds have recently made changes to their positions in CI. Osbon Capital Management LLC bought a new position in shares of Cigna Group in the second quarter worth approximately $26,000. Putney Financial Group LLC bought a new stake in shares of Cigna Group during the 3rd quarter valued at $27,000. Cedar Mountain Advisors LLC raised its position in shares of Cigna Group by 161.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider's stock valued at $29,000 after purchasing an additional 68 shares during the period. Johnson Financial Group Inc. bought a new stake in shares of Cigna Group during the 2nd quarter valued at $29,000. Finally, Fiduciary Financial Advisors purchased a new position in shares of Cigna Group during the 2nd quarter valued at $29,000. 86.99% of the stock is currently owned by institutional investors.

Key Headlines Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Q3 adjusted EPS was $7.98, ahead of analyst estimates, and revenue rose about 6% year over year to $73.79 billion, also exceeding consensus. Cigna cited strength in its healthcare businesses and a favorable drug mix. Read More.
• Positive Sentiment: Management raised its 2026 adjusted earnings outlook to at least $30.60 per share, reinforcing the view that operating performance is improving. Read More.
• Positive Sentiment: Cigna also outlined longer-term targets, including 10%–14% adjusted EPS growth and roughly $50 billion in cumulative operating cash flow through 2030. Its $3 billion “Accelerate to One” initiative is intended to improve productivity and modernize operations. Read More.
• Neutral Sentiment: The planned ACA market exit may simplify Cigna’s business focus, but it also marks a change in its health-insurance footprint. The impact will depend on how the company manages the transition. Read More.
• Negative Sentiment: GAAP net income was $1.44 billion, down from $1.87 billion a year earlier, and reported EPS declined to $5.47 from $6.98. That contrasts with the stronger adjusted results and may temper the headline earnings beat. Read More.

About Cigna Group

The Cigna Group NYSE: CI is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.